Alice L J Carr
Overview
Explore the profile of Alice L J Carr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
117
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Galderisi A, Carr A, Martino M, Taylor P, Senior P, Dayan C
Diabetologia
. 2024 Nov;
68(2):472-473.
PMID: 39592509
No abstract available.
2.
McClure R, Carr A, Boule N, Yardley J
Can J Diabetes
. 2024 May;
48(6):387-393.e2.
PMID: 38735638
Objectives: Expert guidelines recommend an aerobic cooldown to lower blood glucose for the management of post-exercise hyperglycemia. This strategy has never been empirically tested. Our aim in this study was...
3.
Galderisi A, Carr A, Martino M, Taylor P, Senior P, Dayan C
Diabetologia
. 2023 Sep;
66(12):2189-2199.
PMID: 37712956
Clinically symptomatic type 1 diabetes (stage 3 type 1 diabetes) is preceded by a pre-symptomatic phase, characterised by progressive loss of functional beta cell mass after the onset of islet...
4.
Redondo M, Richardson S, Perry D, Minard C, Carr A, Brusko T, et al.
Diabetologia
. 2022 Oct;
66(1):127-131.
PMID: 36282337
Aims/hypothesis: TCF7L2 variants are the strongest genetic risk factor for type 2 diabetes. In individuals with type 1 diabetes, these variants are associated with a higher C-peptide AUC, a lower...
5.
Carr A, Evans-Molina C, Oram R
Diabetologia
. 2022 Aug;
65(11):1854-1866.
PMID: 35994083
First envisioned by early diabetes clinicians, a person-centred approach to care was an aspirational goal that aimed to match insulin therapy to each individual's unique requirements. In the 100 years...
6.
Carr A, Inshaw J, Flaxman C, Leete P, Wyatt R, Russell L, et al.
Diabetes
. 2022 May;
71(7):1591-1596.
PMID: 35499624
C-peptide declines in type 1 diabetes, although many long-duration patients retain low, but detectable levels. Histological analyses confirm that β-cells can remain following type 1 diabetes onset. We explored the...
7.
Niwaha A, Rodgers L, Carr A, Balungi P, Mwebaze R, Hattersley A, et al.
BMJ Open Diabetes Res Care
. 2022 Apr;
10(2).
PMID: 35450869
Introduction: People living with diabetes in low-resource settings may be at increased hypoglycemia risk due to food insecurity and limited access to glucose monitoring. We aimed to assess hypoglycemia risk...
8.
Impouma B, Carr A, Spina A, Mboussou F, Ogundiran O, Moussana F, et al.
Epidemiol Infect
. 2022 Feb;
:1-29.
PMID: 35177157
No abstract available.
9.
Carr A, Oram R, Marren S, McDonald T, Narendran P, Andrews R
J Endocr Soc
. 2021 Aug;
5(10):bvab127.
PMID: 34377883
Context: High-residual C-peptide in longer-duration type 1 diabetes (T1D) is associated with fewer hypoglycemic events and reduced glycemic variability. Little is known about the impact of C-peptide close to diagnosis....
10.
Sims E, Carr A, Oram R, DiMeglio L, Evans-Molina C
Nat Med
. 2021 Jul;
27(7):1154-1164.
PMID: 34267380
The year 2021 marks the centennial of Banting and Best's landmark description of the discovery of insulin. This discovery and insulin's rapid clinical deployment effectively transformed type 1 diabetes from...